Medical News

RSS

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

The investigational drug vupanorsen reduced total levels of non-high-density lipoprotein (non-HDL) cholesterol by up to 28% in patients with high cholesterol who were already taking a cholesterol-lowering statin medication, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease.

3 Apr 2022

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98%

Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental "gene silencing" therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.

3 Apr 2022

First practical guide on the use of digital devices for heart rhythm and rate monitoring published

Who should monitor their heart rate and rhythm and which device should they use? Find out in an international consensus document published today in EP Europace, a journal of the European Society of Cardiology (ESC) and presented at EHRA 2022, a scientific congress of the ESC.

3 Apr 2022

Recommendations to prevent, manage interference in patients with implanted cardiac devices

Recommendations on the prevention and management of interference caused by medical procedures in patients with implanted electronic cardiac devices is published today in EP Europace, a journal of the European Society of Cardiology and presented at EHRA 2022, a scientific congress of the ESC.

3 Apr 2022

Hypertension treatment during pregnancy benefits pregnant women and their babies

Adults treated with medication for high blood pressure present before or during the first 20 weeks of pregnancy, defined as chronic hypertension in pregnancy, had fewer adverse pregnancy outcomes compared to adults who did not receive antihypertensive treatment, according to a study supported by the National Institutes of Health.

2 Apr 2022

Cedars-Sinai’s Los Angeles Barbershop Blood Pressure Study delivers new insights

The Los Angeles Barbershop Blood Pressure Study is delivering cutting-edge insights more than four years after the study results were published in The New England Journal of Medicine.

2 Apr 2022

New evidence on how salt reduction can benefit heart failure patients

For the past century people with weak hearts have been told to lower their salt intake, but until now there has been little scientific evidence behind the recommendation.

2 Apr 2022

High caffeine consumption induces ventricular tachyarrhythmias in rats

The Food and Drug Administration recommends healthy adults not exceed 400 milligrams (mg) of caffeine- approximately four cups of brewed coffee- a day.

2 Apr 2022

Virtual population used to replicate a clinical trial that examines kidney damage in Black Americans

Researchers have successfully used a virtual population to replicate a clinical trial that examined kidney damage in Black Americans, according to a new study at the University of Mississippi Medical Center in Jackson. John S. Clemmer, PhD, a physiologist and lead author of the study, said his team model used a calcium channel blocker to predict kidney damage.

2 Apr 2022

Study lays the groundwork for development of new treatments for Alzheimer's

It's long been known that brain vessel dysfunction induced by a peptide called amyloid-beta (Aβ) could lead to Alzheimer's disease (AD).

2 Apr 2022

Eating prunes every day may reduce pro-inflammatory mediators in postmenopausal women

A study in postmenopausal people suggests eating nutrient-rich prunes every day may be beneficial to bone health, reducing inflammatory factors that contribute to osteoporosis.

2 Apr 2022

Analysis of antioxidants, stress markers in the blood could lead to new diagnostic tool for breast cancer

A new study that analyzes levels of antioxidants and stress markers in the blood could lead to a new diagnostic tool for breast cancer. The research will be presented this week in Philadelphia at the American Physiological Society's annual meeting at Experimental Biology 2022.

2 Apr 2022

Smokers have lower odds of surviving a heart attack than non-smokers

Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid.

2 Apr 2022

High-resistance inspiratory muscle strength training increases exercise tolerance in middle-aged, older adults

Despite the myriad known benefits of exercise, many middle-aged and older adults struggle to meet physical activity recommendations.

2 Apr 2022

Progressive exercise training mitigates negative effects of adverse childhood experiences in young women

New research shows a progressive exercise training program mitigates some physiological and psychological effects of adverse childhood experiences (ACE) in otherwise healthy young women.

2 Apr 2022

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

2 Apr 2022

Health and Social Care Levy to raise billions for tackling Covid backlogs in the UK

From Wednesday 6 April, the first ever dedicated Health and Social Care Levy will begin to raise billions to help tackle Covid backlogs and reform services in the UK.

2 Apr 2022

Clinical health outcomes of omicron ‘less severe’ than delta for pediatric patients

New research from the Case Western Reserve University (CWRU) School of Medicine suggests that the children younger than age 5 who are infected with the COVID-19 Omicron variant have less risk of severe health outcomes than those infected with the Delta variant.

2 Apr 2022

Treating mild hypertension during pregnancy reduces the risk of adverse outcomes

Treating even mildly elevated, or non-severe, blood pressure during pregnancy reduces the risk of adverse pregnancy outcomes and is unlikely to harm the developing baby, according to a study being presented at the American College of Cardiology's (ACC) 71st Annual Scientific Session.

2 Apr 2022

Medical News

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98%

First practical guide on the use of digital devices for heart rhythm and rate monitoring published

Recommendations to prevent, manage interference in patients with implanted cardiac devices

Hypertension treatment during pregnancy benefits pregnant women and their babies

Cedars-Sinai’s Los Angeles Barbershop Blood Pressure Study delivers new insights

New evidence on how salt reduction can benefit heart failure patients

High caffeine consumption induces ventricular tachyarrhythmias in rats

Virtual population used to replicate a clinical trial that examines kidney damage in Black Americans

Study lays the groundwork for development of new treatments for Alzheimer's

Eating prunes every day may reduce pro-inflammatory mediators in postmenopausal women

Analysis of antioxidants, stress markers in the blood could lead to new diagnostic tool for breast cancer

Smokers have lower odds of surviving a heart attack than non-smokers

High-resistance inspiratory muscle strength training increases exercise tolerance in middle-aged, older adults

Progressive exercise training mitigates negative effects of adverse childhood experiences in young women

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Health and Social Care Levy to raise billions for tackling Covid backlogs in the UK

Clinical health outcomes of omicron ‘less severe’ than delta for pediatric patients

Treating mild hypertension during pregnancy reduces the risk of adverse outcomes

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News